Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy

Published:2023-04-27 Issue:9 Volume:50 Page:2636-2646
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Liu Yu,Tang Haocheng,Song Tianchi,Xu Mengxin,Chen Junyi,Cui Xi-Yang,Han Yuxiang,Li Zhu,Liu Zhibo^ORCID

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Ministry of Science and Technology of the People's Republic of China

Special Foundation of Beijing Municipal Education Commission

Li Ge-Zhao Ning Life Science Youth Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00259-023-06230-3.pdf

Reference32 articles.

1. Gill MR, Falzone N, Du Y, Vallis KA. Targeted radionuclide therapy in combined-modality regimens. Lancet Oncol. 2017;18:e414–23.

2. Sartor O, de Bono J, Chi KN, et al. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021;385:1091–103.

3. Gafita A, Calais J, Grogan TR, et al. Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study. Lancet Oncol. 2021;22:1115–25.

4. Langbein T, Weber WA, Eiber M. Future of theranostics: an outlook on precision oncology in nuclear medicine. J Nucl Med. 2019;60:13S-19S.

5. de Swart J, Chan HS, Goorden MC, et al. Utilizing high-energy γ-photons for high-resolution 213Bi SPECT in mice. J Nucl Med. 2016;57:486–92.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of fibroblast activation protein-α radiopharmaceuticals: Recent advances and perspectives;European Journal of Medicinal Chemistry;2024-11

2. Noninvasive strategies of cell-tracking in vivo;TrAC Trends in Analytical Chemistry;2024-03

3. Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy;European Journal of Medicinal Chemistry;2024-03

4. Synthesis and preclinical evaluation of novel 18F-labeled fibroblast activation protein tracers for positron emission tomography imaging of cancer-associated fibroblasts;European Journal of Medicinal Chemistry;2024-01

5. ²²⁵Ac-Labeled Antibody for Fibroblast Activation Protein-Targeted Alpha Therapy;Chemical & Biomedical Imaging;2023-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3